Anticancer Drugs Flashcards
most important efflux pump responsible for multidrug resistance
p-glycoprotein aka multidrug resistant protein 1 (MDR1)
cell cycle specific agents
B-AMEC
Bleomycin Antimetabolites Microtubule inhibitors Epipodophyllotoxins Camptothecins
what are the cell cycle non specific agents
Alkylating Agents
Platinum coordination complexes
Antitumor antibiotics (minus Bleomycin)
what are the antimetabolites
Folate analogues: Methotrexate
Purine analogues: 6-mercaptopurine and 6-thioguanine
Pyrimidine analogues: Fluoropyrimidines (5-fluorouracil and capecitabine) and Deoxycytidine analogues (cytarabine and gemcitabine)
what inhibits the renal excretion of methotrexate
CANP
Cephalosporin
Aspirin
NSAIDs
Penicillin
mechanism of action of methotrexate
catalyzed by folylpolyglutamate synthetase to MTX polyglutamate –> inhibits dihydrofolate reductase –> no THF –> needed for deoxythymidylate nucleotides and purine nucleotides
what drug is used in conjunction with MTX and why
Leucovorin, derivative of THF, to rescue normal cells from toxicity and overcome accidental drug overdose
adverse effects of MTX
a lot can be resolved with leucovorin
Myelosuppression
Pulmonary Fibrosis
mechanism of 6-mercaptopurine
converted to 6-MP ribose phosphate (or thio-inosinic acid or TIMP) by HGPRT –> inhibits phosphoribosyl pyrophosphate amidotransferase –> needed for de novo purine synthesis
what drugs/deficiency can make 6-mercaptopurine toxic
- it is metabolized by xanthine oxidase so if given with allopurinol which inhibits the enzyme then 6-MP will reach toxic level if dose not reduced
- also metabolized by TPMT (thiopurine methyltransferase) so if deficiency in allele, 6-MP can reach toxic levels if dose not reduced
mechanism of thioguanine
converted to nucleotide thioguanosine monophosphate (TGMP) by HGPRT
- inhibits PRPP amidotransferase which inhibits purine synthesis
- inhibits Guanylate kinase so can’t go from GMP to GDP
- can be converted to TGTP and dTGTP which can be incorporated into RNA and DNA respectively
what can make a normal dose of thioguanine toxic
TPMT (thiopurine methyltransferase) deficiency hence thioguanine dose must be reduced
it is inactivated by deamination (not oxidation) so xanthine oxidase (allopurinol) does not play a role here
when treating adult acute leukemia, what drug is thioguanine used synergistically with
Cytarabine
first line drug for colorectal cancer
5-fluorouracil
mechanism of 5-fluorouracil
converted to FdUMP which forms a tertiary complex with thymidylate synthase and reduced folate (N5, N10, and methylene THF) –> inhibition of DNA synthesis
what potentiates the activity of 5-fluorouracil
increasing level of the reduced folate - N5, N10, and methylene THF
what can cause a normal dose of 5-fluorouracil to become toxic
deficiency of dihydropyrimidine dehydrogenase (DPD), the enzyme that metabolized it